Skip to Content

FluLaval Approval History

  • FDA approved: Yes (First approved October 5th, 2006)
  • Brand name: FluLaval
  • Generic name: Influenza Virus Vaccine
  • Company: GlaxoSmithKline
  • Treatment for: Influenza Prophylaxis

FluLaval (Influenza Virus Vaccine) is indicated for the active immunization of adults 18 years and older against influenza disease caused by influenza virus types A and B contained in the vaccine.

Development History and FDA Approval Process for FluLaval

Oct  5, 2006Approval FluLaval GlaxoSmithKline - Treatment for Prevention of Influenza
Mar 23, 2006GlaxoSmithKline Submits Biologics License Application for FDA Approval of FluLaval

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.